1-5 of 5
Keywords: Oxiracetam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Double-Blind Placebo-Controlled, Neuropsychological and Neurophysiological Investigations with Oxiracetam (CGP 21690E) in Memory-Impaired Patients with Epilepsy

Subject Area:
Neurology and Neuroscience , Psychiatry and Psychology
A.P. Aldenkamp, A. van Wieringen, W.C.J. Alpherts, W. van Emde Boas, H.A. Haverkort, J. de Vries, H. Meinardi
Journal: Neuropsychobiology
Neuropsychobiology (1990) 24 (2): 90–101.
https://doi.org/10.1159/000119467
Published Online: 27 February 2008
...A.P. Aldenkamp; A. van Wieringen; W.C.J. Alpherts; W. van Emde Boas; H.A. Haverkort; J. de Vries; H. Meinardi A double-blind placebo-controlled between-patient study was carried out to assess the effects of oxiracetam (CGP 21690E) on memory function in patients with epilepsy. During a 12-week...
View article titled, Double-Blind Placebo-Controlled, Neuropsychological and Neurophysiological Investigations with <span class="search-highlight">Oxiracetam</span> (CGP 21690E) in Memory-Impaired Patients with Epilepsy
Open the PDF for Double-Blind Placebo-Controlled, Neuropsychological and Neurophysiological Investigations with <span class="search-highlight">Oxiracetam</span> (CGP 21690E) in Memory-Impaired Patients with Epilepsy in another window
Journal Articles

Neuropsychological Results of Long-Term Therapy with Oxiracetam in Patients with Dementia of Alzheimer Type and Multi-Infarct Dementia in Comparison with a Control Group

Subject Area:
Neurology and Neuroscience , Psychiatry and Psychology
L. Parnetti, P. Mecocci, A. Petrini, A. Longo, A. Buccolieri, U. Senin
Journal: Neuropsychobiology
Neuropsychobiology (1989) 22 (2): 97–100.
https://doi.org/10.1159/000118599
Published Online: 20 February 2008
...L. Parnetti; P. Mecocci; A. Petrini; A. Longo; A. Buccolieri; U. Senin The cognitive and behavioral effects of oxiracetam therapy during long-term treatment in patients with dementia of Alzheimer type (DAT) and multi-infarct dementia (MID) were studied in comparison with a historical control group...
View article titled, Neuropsychological Results of Long-Term Therapy with <span class="search-highlight">Oxiracetam</span> in Patients with Dementia of Alzheimer Type and Multi-Infarct Dementia in Comparison with a Control Group
Open the PDF for Neuropsychological Results of Long-Term Therapy with <span class="search-highlight">Oxiracetam</span> in Patients with Dementia of Alzheimer Type and Multi-Infarct Dementia in Comparison with a Control Group in another window
Journal Articles

Oxiracetam in the Treatment of Primary Degenerative and Multi-Infarct Dementia: A Double-Blind, Placebo-Controlled Study

Subject Area:
Neurology and Neuroscience , Psychiatry and Psychology
G. Maina, L. Fiori, R. Torta, M.B. Fagiani, L. Ravizza, E. Bonavita, B. Ghiazza, F. Teruzzi, P.G. Zagnoni, E. Ferrario, G. Belloni, G. Tass, M.R. Inzoli, G. Lombardi, G.B. Voltolini, G. Gherardi, A. Martinazzoli, U. Straneo, P.A. Bernini, P. Mazzocchi, G. Belloni, M. Soldati, M. Stramba-Badiale, C. Castoldi, F.A. Rossi, G.E. Balladore, D.M. Macciolli
Journal: Neuropsychobiology
Neuropsychobiology (1989) 21 (3): 141–145.
https://doi.org/10.1159/000118567
Published Online: 20 February 2008
.... Castoldi; F.A. Rossi; G.E. Balladore; D.M. Macciolli A multicentre, double-blind, between-patient study was carried out to evaluate the efficacy and tolerability of oxiracetam (800-mg tablets), in comparison with placebo, each given twice daily for 12 weeks to patients suffering from primary degenerative...
View article titled, <span class="search-highlight">Oxiracetam</span> in the Treatment of Primary Degenerative and Multi-Infarct Dementia: A Double-Blind, Placebo-Controlled Study
Open the PDF for <span class="search-highlight">Oxiracetam</span> in the Treatment of Primary Degenerative and Multi-Infarct Dementia: A Double-Blind, Placebo-Controlled Study in another window
Journal Articles

Double-Blind, Placebo-Controlled, Clinical, Psychometric and Neurophysiological Investigations with Oxiracetam in the Organic Brain Syndrome of Late Life

Subject Area:
Neurology and Neuroscience , Psychiatry and Psychology
B. Saletu, L. Linzmayer, J. Grünberger, H. Pietschmann
Journal: Neuropsychobiology
Neuropsychobiology (1985) 13 (1-2): 44–52.
https://doi.org/10.1159/000118161
Published Online: 19 February 2008
...B. Saletu; L. Linzmayer; J. Grünberger; H. Pietschmann The therapeutic efficacy and safety of oxiracetam (ISF 2522), a new nootropic cyclic GABA derivative, were investigated in a double-blind, placebo-controlled study in 40 patients with organic brain syndrome in late life. The psychopathology...
View article titled, Double-Blind, Placebo-Controlled, Clinical, Psychometric and Neurophysiological Investigations with <span class="search-highlight">Oxiracetam</span> in the Organic Brain Syndrome of Late Life
Open the PDF for Double-Blind, Placebo-Controlled, Clinical, Psychometric and Neurophysiological Investigations with <span class="search-highlight">Oxiracetam</span> in the Organic Brain Syndrome of Late Life in another window
Journal Articles

Clinical Studies with Oxiracetam in Patients with Dementia of Alzheimer Type and Multi-lnfarct Dementia of Mild to Moderate Degree

Subject Area:
Neurology and Neuroscience , Psychiatry and Psychology
C. Villardita, S. Grioli, C. Lomeo, C. Cattaneo, J. Parini
Journal: Neuropsychobiology
Neuropsychobiology (1992) 25 (1): 24–28.
https://doi.org/10.1159/000118805
Published Online: 01 January 1992
...C. Villardita; S. Grioli; C. Lomeo; C. Cattaneo; J. Parini The cognitive and behavioral effects and the safety of oxiracetam therapy during a placebo-controlled trial and the relevant follow-up up to 1 year in patients with senile dementia of Alzheimer type (SDAT) and multi-infarct dementia (MID...
View article titled, Clinical Studies with <span class="search-highlight">Oxiracetam</span> in Patients with Dementia of Alzheimer Type and Multi-lnfarct Dementia of Mild to Moderate Degree
Open the PDF for Clinical Studies with <span class="search-highlight">Oxiracetam</span> in Patients with Dementia of Alzheimer Type and Multi-lnfarct Dementia of Mild to Moderate Degree in another window